abstract
- Clinical trials show that strategies to elicit the production of broadly neutralizing antibodies have a promising start.
Evolving rare B cell lineages for an effective HIV vaccine.
Overview
authors
publication date
- July 31, 2025
published in
- Science (New York, N.Y.) Journal
Research
keywords
- AIDS Vaccines
- B-Lymphocytes
- Broadly Neutralizing Antibodies
- HIV Antibodies
- HIV Infections
- HIV-1
Identity
Digital Object Identifier (DOI)
- 10.1126/science.adz6436
PubMed ID
- 40743359
Additional Document Info
volume
- 389
issue
- 6759